Micromet, Inc. (MITI) Reports Q2 EPS Loss of $0.19
Tweet
Share
E-mailGet Alerts MITI Hot Sheet
Price: $0.03 --0%
Financial Fact:
Total operating expenses: 25.23M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total operating expenses: 25.23M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Micromet, Inc. (NASDAQ: MITI) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.24 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mitesco halts Series A Preferred stock redemptions amid shareholder concerns
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Tapestry (TPR) Tops Q4 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
